Editorial: Mesenchymal Stromal Cell Therapy for Regenerative Medicine

• Vivian Capilla-González,
• Vicente Herranz-Pérez,
• Rachel Sarabia-Estrada,
• Nadir Kadri,
• Nadir Kadri,
• Guido Moll

Affiliations

Vivian Capilla-González

Department of Regeneration and Cell Therapy, Andalusian Center of Molecular Biology and Regenerative Medicine (CABIMER)-University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain

Vicente Herranz-Pérez

Department of Cell Biology, Functional Biology and Physical Anthropology, School of Biological Sciences, University of Valencia, Valencia, Spain

Rachel Sarabia-Estrada

Department of Neurologic Surgery, Mayo Clinic Florida, Jacksonville, FL, United States

Nadir Kadri

Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

Nadir Kadri

Science for Life Laboratory (SciLife), Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden

Guido Moll

BIH Center for Regenerative Therapies (BCRT) and Berlin-Brandenburg School for Regenerative Therapies (BSRT), Berlin Institute of Health (BIH) at the Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany